Ann Dilworth
About Ann Dilworth
Ann Dilworth is a Data Management Liaison and Therapeutic Area Lead at Bristol-Myers Squibb, with extensive experience in clinical operations and team management.
Title and Role at Bristol-Myers Squibb
Ann Dilworth currently holds multiple roles at Bristol-Myers Squibb, including Data Management Liaison, Regional Clinical Operations - Americas, Therapeutic Area Lead Full Development Immuno-Oncology, and Head of East Region, US Site Monitoring. Based in Falmouth, Maine, she oversees a wide range of operations within the company, particularly focusing on regional clinical operations and immuno-oncology program leadership.
Education and Expertise
Ann Dilworth holds a Master of Public Health (M.P.H.) from Boston University and has also studied at The University of Connecticut. Her educational background has equipped her with a robust foundation in public health principles and practices, further enhancing her expertise in data management, clinical trials, and oncology.
Leadership and Team Management
In her role at Bristol-Myers Squibb, Ann oversees a team of 60 Clinical Research Associates (CRAs) within a matrix organization. She has extensive experience in functional leadership, team development, and performance management. Ann focuses on driving team performance, fostering continuous improvement, and managing change effectively.
Clinical Trial and Data Management Expertise
Ann possesses in-depth knowledge and skills in Clinical Trial Management System (CTMS), Risk Based Monitoring, Oncology, Clinical Trials, and Good Clinical Practice (GCP). Her extensive experience in global program/trial execution includes monitoring modalities and strategic clinical relationship development. This makes her highly proficient in managing and executing clinical trials effectively.
Strategic Thinking and Problem-Solving Skills
Ann Dilworth is recognized for her strategic thinking, stakeholder management, and problem-solving abilities. Her role encompasses driving performance, fostering continuous growth, and implementing change management strategies. Her skills contribute significantly to the operational excellence and strategic direction of Bristol-Myers Squibb's clinical operations.